Safety and efficacy of a novel drug elores (ceftriaxone + sulbactam + disodium edetate) in the management of multi-drug resistant bacterial infections in tertiary care centers: a post-marketing surveillance study

OBJECTIVE: In India, Elores (CSE-1034: ceftriaxone + sulbactam + disodium edetate) was approved as a broad spectrum antibiotic in year 2011 and is used for management of Extended Spectrum Beta Lactamases/Metallo Beta lactamases infections in tertiary care centers. The objective of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaudhary, Manu, Mir, Mohd Amin, Ayub, Shiekh Gazalla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427805/
https://www.ncbi.nlm.nih.gov/pubmed/28376315
http://dx.doi.org/10.1016/j.bjid.2017.02.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427805/
https://www.ncbi.nlm.nih.gov/pubmed/28376315
http://dx.doi.org/10.1016/j.bjid.2017.02.007

Ejemplares similares